Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CadenTinA-asthma: Tiotropium Respimat in Moderate to Severe Persistent Asthma
NCT01340209Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiotropium in asthma, sponsored by Boehringer Ingelheim. Started Apr 2011; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01340209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01340209.